000200155712/312025Q1falsexbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureinnv:extension_optioninnv:instrumentinnv:dayinnv:voteinnv:granteeinnv:directorinnv:agreementiso4217:EURinnv:segment00020015572025-01-012025-03-3100020015572025-04-2500020015572025-03-3100020015572024-12-310002001557us-gaap:RelatedPartyMember2025-03-310002001557us-gaap:RelatedPartyMember2024-12-310002001557us-gaap:NonrelatedPartyMember2025-03-310002001557us-gaap:NonrelatedPartyMember2024-12-3100020015572024-01-012024-03-310002001557us-gaap:NonrelatedPartyMember2025-01-012025-03-310002001557us-gaap:NonrelatedPartyMember2024-01-012024-03-310002001557us-gaap:RelatedPartyMember2025-01-012025-03-310002001557us-gaap:RelatedPartyMember2024-01-012024-03-310002001557us-gaap:PreferredStockMemberus-gaap:PreferredClassBMember2023-12-310002001557us-gaap:PreferredStockMemberinnv:PreferredClassB1Member2023-12-310002001557us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-12-310002001557us-gaap:CommonStockMemberus-gaap:CommonClassCMember2023-12-310002001557us-gaap:RetainedEarningsMember2023-12-310002001557us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310002001557us-gaap:NoncontrollingInterestMember2023-12-3100020015572023-12-310002001557us-gaap:RetainedEarningsMember2024-01-012024-03-310002001557us-gaap:NoncontrollingInterestMember2024-01-012024-03-310002001557us-gaap:PreferredStockMemberus-gaap:PreferredClassBMember2024-01-012024-03-310002001557us-gaap:CommonStockMemberus-gaap:CommonClassCMember2024-01-012024-03-310002001557us-gaap:PreferredStockMemberus-gaap:PreferredClassBMember2024-03-310002001557us-gaap:PreferredStockMemberinnv:PreferredClassB1Member2024-03-310002001557us-gaap:CommonStockMemberus-gaap:CommonClassAMember2024-03-310002001557us-gaap:CommonStockMemberus-gaap:CommonClassCMember2024-03-310002001557us-gaap:RetainedEarningsMember2024-03-310002001557us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310002001557us-gaap:NoncontrollingInterestMember2024-03-3100020015572024-03-310002001557us-gaap:PreferredStockMember2024-12-310002001557us-gaap:CommonStockMember2024-12-310002001557us-gaap:AdditionalPaidInCapitalMember2024-12-310002001557us-gaap:RetainedEarningsMember2024-12-310002001557us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310002001557us-gaap:NoncontrollingInterestMember2024-12-310002001557us-gaap:RetainedEarningsMember2025-01-012025-03-310002001557us-gaap:NoncontrollingInterestMember2025-01-012025-03-310002001557us-gaap:PreferredStockMember2025-01-012025-03-310002001557us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310002001557us-gaap:CommonStockMember2025-01-012025-03-310002001557us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310002001557us-gaap:PreferredStockMember2025-03-310002001557us-gaap:CommonStockMember2025-03-310002001557us-gaap:AdditionalPaidInCapitalMember2025-03-310002001557us-gaap:RetainedEarningsMember2025-03-310002001557us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310002001557us-gaap:NoncontrollingInterestMember2025-03-310002001557srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2025-03-310002001557srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2025-01-012025-03-310002001557innv:AeroFlexxLLCMember2025-03-310002001557innv:AeroFlexxLLCMember2024-12-310002001557innv:AeroFlexxLLCMember2024-07-010002001557innv:AeroFlexxLLCMember2025-01-012025-01-010002001557innv:AeroFlexxLLCMember2025-01-012025-03-310002001557us-gaap:FairValueInputsLevel1Member2025-03-310002001557us-gaap:FairValueInputsLevel2Member2025-03-310002001557us-gaap:FairValueInputsLevel3Member2025-03-310002001557innv:WTIWarrantMemberus-gaap:FairValueInputsLevel1Member2025-03-310002001557innv:WTIWarrantMemberus-gaap:FairValueInputsLevel2Member2025-03-310002001557innv:WTIWarrantMemberus-gaap:FairValueInputsLevel3Member2025-03-310002001557innv:WTIWarrantMember2025-03-310002001557innv:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel1Member2025-03-310002001557innv:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Member2025-03-310002001557innv:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Member2025-03-310002001557innv:PrivatePlacementWarrantsMember2025-03-310002001557us-gaap:FairValueInputsLevel1Member2024-12-310002001557us-gaap:FairValueInputsLevel2Member2024-12-310002001557us-gaap:FairValueInputsLevel3Member2024-12-310002001557innv:WTIWarrantMemberus-gaap:FairValueInputsLevel1Member2024-12-310002001557innv:WTIWarrantMemberus-gaap:FairValueInputsLevel2Member2024-12-310002001557innv:WTIWarrantMemberus-gaap:FairValueInputsLevel3Member2024-12-310002001557innv:WTIWarrantMember2024-12-310002001557innv:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel1Member2024-12-310002001557innv:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Member2024-12-310002001557innv:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Member2024-12-310002001557innv:PrivatePlacementWarrantsMember2024-12-310002001557us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2023-12-310002001557us-gaap:AvailableforsaleSecuritiesMember2023-12-310002001557innv:LiabilityClassifiedEarnoutSharesMember2023-12-310002001557us-gaap:WarrantMember2023-12-310002001557us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2024-01-012024-03-310002001557us-gaap:AvailableforsaleSecuritiesMember2024-01-012024-03-310002001557innv:LiabilityClassifiedEarnoutSharesMember2024-01-012024-03-310002001557us-gaap:WarrantMember2024-01-012024-03-310002001557us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2024-03-310002001557us-gaap:AvailableforsaleSecuritiesMember2024-03-310002001557innv:LiabilityClassifiedEarnoutSharesMember2024-03-310002001557us-gaap:WarrantMember2024-03-310002001557us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2024-12-310002001557us-gaap:AvailableforsaleSecuritiesMember2024-12-310002001557innv:LiabilityClassifiedEarnoutSharesMember2024-12-310002001557us-gaap:WarrantMember2024-12-310002001557us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2025-01-012025-03-310002001557us-gaap:AvailableforsaleSecuritiesMember2025-01-012025-03-310002001557us-gaap:WarrantMember2025-01-012025-03-310002001557innv:LiabilityClassifiedEarnoutSharesMember2025-01-012025-03-310002001557us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2025-03-310002001557us-gaap:AvailableforsaleSecuritiesMember2025-03-310002001557innv:LiabilityClassifiedEarnoutSharesMember2025-03-310002001557us-gaap:WarrantMember2025-03-310002001557us-gaap:MeasurementInputPriceVolatilityMember2024-12-310002001557us-gaap:MeasurementInputExpectedTermMember2024-12-310002001557us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember2024-12-310002001557innv:MeasurementInputWeightedAverageCostOfCapitalMember2024-12-310002001557us-gaap:MeasurementInputRiskFreeInterestRateMember2024-12-310002001557us-gaap:MeasurementInputQuotedPriceMember2025-03-310002001557us-gaap:MeasurementInputExpectedTermMember2025-03-310002001557us-gaap:MeasurementInputSharePriceMember2025-03-310002001557us-gaap:MeasurementInputSharePriceMember2024-12-310002001557us-gaap:MeasurementInputPriceVolatilityMember2025-03-310002001557us-gaap:MeasurementInputRiskFreeInterestRateMember2025-03-310002001557us-gaap:MeasurementInputExpectedDividendRateMember2025-03-310002001557us-gaap:MeasurementInputExpectedDividendRateMember2024-12-310002001557innv:MeasurementInputRevenueRiskPremiumMember2025-03-310002001557innv:MeasurementInputRevenueRiskPremiumMember2024-12-310002001557innv:MeasurementInputRevenueVolatilityMember2025-03-310002001557innv:MeasurementInputRevenueVolatilityMember2024-12-310002001557us-gaap:MeasurementInputCreditSpreadMember2025-03-310002001557us-gaap:MeasurementInputCreditSpreadMember2024-12-310002001557innv:Series1PromissoryNotesMemberus-gaap:NotesPayableOtherPayablesMemberus-gaap:NonrelatedPartyMember2025-03-310002001557us-gaap:NonrelatedPartyMemberus-gaap:NotesPayableOtherPayablesMember2025-03-310002001557innv:Series1PromissoryNotesMemberus-gaap:NotesPayableOtherPayablesMemberus-gaap:NonrelatedPartyMember2024-12-310002001557us-gaap:NotesPayableOtherPayablesMemberus-gaap:NonrelatedPartyMembersrt:MinimumMember2024-12-310002001557innv:Series1PromissoryNotesMemberus-gaap:NotesPayableOtherPayablesMemberus-gaap:NonrelatedPartyMembersrt:MaximumMember2024-12-310002001557innv:RelatedPartyNoteMemberus-gaap:NotesPayableOtherPayablesMemberus-gaap:RelatedPartyMember2025-03-310002001557innv:RelatedPartyNoteMemberus-gaap:NotesPayableOtherPayablesMemberus-gaap:RelatedPartyMember2024-12-310002001557innv:RelatedPartyNoteMemberus-gaap:NotesPayableOtherPayablesMemberus-gaap:RelatedPartyMembersrt:MinimumMember2024-12-310002001557innv:RelatedPartyNoteMemberus-gaap:NotesPayableOtherPayablesMemberus-gaap:RelatedPartyMembersrt:MaximumMember2024-12-310002001557innv:WTIFacilityMemberus-gaap:SecuredDebtMember2025-03-310002001557innv:WTIFacilityMemberus-gaap:SecuredDebtMember2024-12-310002001557innv:Series1PromissoryNotesMemberus-gaap:NotesPayableOtherPayablesMember2018-12-310002001557innv:Series1PromissoryNotesMemberus-gaap:NotesPayableOtherPayablesMember2021-12-310002001557innv:Series1PromissoryNotesMemberus-gaap:NotesPayableOtherPayablesMembersrt:MinimumMember2021-12-312021-12-310002001557innv:Series1PromissoryNotesMemberus-gaap:NotesPayableOtherPayablesMembersrt:MaximumMember2021-12-312021-12-310002001557innv:Series1PromissoryNotesMemberus-gaap:NotesPayableOtherPayablesMembersrt:MinimumMember2021-12-310002001557innv:Series1PromissoryNotesMemberus-gaap:NotesPayableOtherPayablesMembersrt:MaximumMember2021-12-310002001557innv:Series1PromissoryNotesMemberus-gaap:NotesPayableOtherPayablesMember2021-12-312021-12-310002001557innv:Series1PromissoryNotesFirstTermExtensionMemberus-gaap:NotesPayableOtherPayablesMember2021-12-310002001557innv:Series1PromissoryNotesFirstTermExtensionMemberus-gaap:NotesPayableOtherPayablesMembersrt:MinimumMember2021-12-312021-12-310002001557innv:Series1PromissoryNotesFirstTermExtensionMemberus-gaap:NotesPayableOtherPayablesMembersrt:MaximumMember2021-12-312021-12-310002001557innv:Series1PromissoryNotesSecondTermExtensionMemberus-gaap:NotesPayableOtherPayablesMember2021-12-310002001557innv:Series1PromissoryNotesSecondTermExtensionMemberus-gaap:NotesPayableOtherPayablesMembersrt:MinimumMember2021-12-312021-12-310002001557innv:Series1PromissoryNotesSecondTermExtensionMemberus-gaap:NotesPayableOtherPayablesMembersrt:MaximumMember2021-12-312021-12-310002001557innv:Series1PromissoryNotesFirstTermExtensionMemberus-gaap:NotesPayableOtherPayablesMember2025-01-012025-03-310002001557innv:Series1PromissoryNotesFirstTermExtensionMemberus-gaap:NotesPayableOtherPayablesMember2024-01-012024-03-310002001557innv:Series1PromissoryNotesSecondTermExtensionMemberus-gaap:NotesPayableOtherPayablesMember2025-01-012025-03-310002001557innv:Series1PromissoryNotesSecondTermExtensionMemberus-gaap:NotesPayableOtherPayablesMember2024-01-012024-03-310002001557innv:Series1PromissoryNotesMemberus-gaap:NotesPayableOtherPayablesMember2025-01-012025-03-310002001557innv:Series1PromissoryNotesMemberus-gaap:NotesPayableOtherPayablesMember2024-01-012024-03-310002001557innv:RelatedPartyNoteMemberus-gaap:NotesPayableOtherPayablesMember2024-08-220002001557innv:RelatedPartyNoteOneMemberus-gaap:NotesPayableOtherPayablesMember2024-08-200002001557innv:RelatedPartyNoteTwoMemberus-gaap:NotesPayableOtherPayablesMember2024-08-220002001557innv:RelatedPartyNoteOneMemberus-gaap:NotesPayableOtherPayablesMember2024-10-010002001557innv:RelatedPartyNoteTwoMemberus-gaap:NotesPayableOtherPayablesMember2024-10-010002001557innv:RelatedPartyNoteMemberus-gaap:NotesPayableOtherPayablesMember2025-01-012025-03-310002001557innv:RelatedPartyNoteMemberus-gaap:NotesPayableOtherPayablesMember2024-01-012024-03-310002001557innv:RelatedPartyNoteThreeMemberus-gaap:NotesPayableOtherPayablesMember2024-05-020002001557innv:WTIFacilityMemberus-gaap:SecuredDebtMember2024-10-220002001557innv:WTIFacilityTrancheOneMemberus-gaap:SecuredDebtMember2024-11-152024-11-150002001557innv:WTIFacilityMemberus-gaap:SecuredDebtMember2024-10-222024-10-220002001557innv:WTIFacilityTrancheOneMemberus-gaap:SecuredDebtMember2024-10-222024-10-220002001557innv:WTIFacilityMemberus-gaap:SecuredDebtMember2025-01-012025-03-310002001557innv:WTIFacilityMemberus-gaap:SecuredDebtMember2024-01-012024-03-310002001557innv:ConvertibleDebenturesMemberus-gaap:ConvertibleDebtMember2025-03-2500020015572025-03-250002001557us-gaap:LeaseholdImprovementsMember2025-03-310002001557us-gaap:LeaseholdImprovementsMember2024-12-310002001557us-gaap:MachineryAndEquipmentMember2025-03-310002001557us-gaap:MachineryAndEquipmentMember2024-12-310002001557innv:ComputerAndOfficeEquipmentMember2025-03-310002001557innv:ComputerAndOfficeEquipmentMember2024-12-310002001557us-gaap:ConstructionInProgressMember2025-03-310002001557us-gaap:ConstructionInProgressMember2024-12-310002001557us-gaap:TradeNamesMember2025-03-310002001557us-gaap:TradeNamesMember2024-12-310002001557us-gaap:CustomerRelationshipsMember2025-03-310002001557us-gaap:CustomerRelationshipsMember2024-12-310002001557us-gaap:DevelopedTechnologyRightsMember2025-03-310002001557us-gaap:DevelopedTechnologyRightsMember2024-12-310002001557us-gaap:OtherIntangibleAssetsMember2025-03-310002001557us-gaap:OtherIntangibleAssetsMember2024-12-310002001557innv:InnventureLLCMemberinnv:InnventureMembersMember2024-10-020002001557innv:InnventureLLCMemberinnv:SponsorMember2024-10-020002001557innv:InnventureLLCMemberinnv:SponsorMember2025-01-072025-01-070002001557innv:InnventureLLCMember2024-10-020002001557innv:InnventureLLCMember2024-10-022024-10-020002001557innv:InnventureLLCMemberinnv:ContingentConsiderationSharesMilestoneTwoMember2025-02-042025-02-040002001557innv:InnventureLLCMemberinnv:ContingentConsiderationSharesMilestoneThreeMember2025-03-310002001557innv:InnventureLLCMemberinnv:ContingentConsiderationSharesMilestoneThreeMember2024-12-310002001557innv:InnventureLLCMemberinnv:ContingentConsiderationSharesMilestoneThreeMember2025-01-012025-03-310002001557innv:PublicWarrantsMember2024-12-310002001557innv:PublicWarrantsMember2025-01-012025-03-310002001557innv:PrivatePlacementWarrantsMember2025-01-012025-03-310002001557innv:WTIWarrantMember2025-01-012025-03-310002001557innv:PublicWarrantsMember2025-03-310002001557us-gaap:SeriesBPreferredStockMember2025-03-310002001557us-gaap:SeriesBPreferredStockMember2025-01-012025-03-310002001557us-gaap:SeriesBPreferredStockMember2025-03-192025-03-190002001557us-gaap:SeriesCPreferredStockMember2025-03-310002001557us-gaap:SeriesCPreferredStockMember2025-03-242025-03-240002001557us-gaap:SeriesCPreferredStockMember2025-01-012025-03-310002001557innv:StandbyEquityPurchaseAgreementMember2023-10-012023-10-310002001557innv:StandbyEquityPurchaseAgreementMember2023-10-310002001557innv:StandbyEquityPurchaseAgreementMember2025-01-012025-03-310002001557innv:StandbyEquityPurchaseAgreementMember2025-03-310002001557innv:FinancialAdvisorMember2023-12-012023-12-310002001557us-gaap:CommonStockMemberinnv:FinancialAdvisorMember2023-12-012023-12-310002001557innv:WTILenderMember2024-10-222024-10-220002001557us-gaap:CommonStockMemberinnv:WTILenderMember2024-10-222024-10-220002001557us-gaap:CommonStockMember2023-12-012025-02-0300020015572023-10-012023-10-310002001557us-gaap:SeriesCPreferredStockMember2023-10-012023-10-310002001557us-gaap:SeriesCPreferredStockMember2023-10-310002001557us-gaap:SeriesCPreferredStockMember2023-10-012025-03-240002001557us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-03-310002001557us-gaap:RestrictedStockUnitsRSUMember2025-03-3100020015572025-02-262025-02-260002001557us-gaap:EmployeeStockOptionMember2025-02-262025-02-260002001557us-gaap:EmployeeStockOptionMember2025-01-012025-03-310002001557us-gaap:StockAppreciationRightsSARSMemberinnv:AccelsiusHoldingsLLCMember2024-01-012024-12-310002001557us-gaap:StockAppreciationRightsSARSMemberinnv:AccelsiusHoldingsLLCMember2024-12-310002001557us-gaap:StockAppreciationRightsSARSMemberinnv:AccelsiusHoldingsLLCMember2025-01-012025-03-310002001557innv:AccelciusSubsidiaryEquityPlanMember2025-01-012025-03-310002001557innv:AccelciusSubsidiaryEquityPlanMember2024-01-012024-03-310002001557innv:AccelciusSubsidiaryEquityPlanMember2025-03-310002001557innv:PublicWarrantsMember2025-01-012025-03-310002001557innv:PrivatePlacementWarrantsMember2025-01-012025-03-310002001557innv:WTIWarrantMember2025-01-012025-03-310002001557us-gaap:SeriesBPreferredStockMember2025-01-012025-03-310002001557us-gaap:SeriesCPreferredStockMember2025-01-012025-03-310002001557us-gaap:EmployeeStockOptionMember2025-01-012025-03-310002001557us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-03-310002001557us-gaap:StockAppreciationRightsSARSMember2025-01-012025-03-310002001557us-gaap:RelatedPartyMember2025-03-202025-03-200002001557us-gaap:RestrictedStockUnitsRSUMemberus-gaap:RelatedPartyMemberinnv:TransactionsWithDirectorsMember2024-12-092024-12-090002001557us-gaap:RelatedPartyMemberinnv:TransactionsWithDirectorsMember2024-12-092024-12-090002001557us-gaap:EmployeeStockOptionMemberus-gaap:RelatedPartyMemberinnv:TransactionsWithDirectorsMember2024-12-092024-12-090002001557us-gaap:StockAppreciationRightsSARSMemberus-gaap:RelatedPartyMemberinnv:TransactionsWithDirectorsMember2024-12-312024-12-310002001557us-gaap:RelatedPartyMemberinnv:TransactionsWithDirectorsMember2024-12-312024-12-310002001557us-gaap:RelatedPartyMemberinnv:ClassCUnitsMemberinnv:TransactionsWithDirectorsMember2024-03-222024-03-220002001557us-gaap:RelatedPartyMemberinnv:TransactionsWithDirectorsMember2024-03-222024-03-220002001557us-gaap:RelatedPartyMembersrt:MinimumMemberinnv:TransactionsWithESGFundMember2025-01-012025-03-310002001557us-gaap:RelatedPartyMembersrt:MaximumMemberinnv:TransactionsWithESGFundMember2025-01-012025-03-310002001557us-gaap:RelatedPartyMemberinnv:ManagementFeesMemberinnv:TransactionsWithESGFundMember2025-01-012025-03-310002001557us-gaap:RelatedPartyMemberinnv:ManagementFeesMemberinnv:TransactionsWithESGFundMember2024-01-012024-03-310002001557us-gaap:RelatedPartyMemberinnv:TransactionsWithESGFundMember2021-03-310002001557us-gaap:RelatedPartyMemberinnv:TransactionsWithAeroFlexxMember2025-03-242025-03-2400020015572020-04-2200020015572020-04-222025-03-3100020015572022-01-012022-12-3100020015572024-12-1200020015572025-01-220002001557innv:TechnologySegmentMember2025-01-012025-03-310002001557innv:TechnologySegmentMember2024-01-012024-03-310002001557us-gaap:OperatingSegmentsMemberinnv:TechnologySegmentMember2025-01-012025-03-310002001557us-gaap:OperatingSegmentsMemberinnv:TechnologySegmentMember2024-01-012024-03-310002001557us-gaap:CorporateNonSegmentMember2025-01-012025-03-310002001557us-gaap:CorporateNonSegmentMember2024-01-012024-03-310002001557us-gaap:IntersegmentEliminationMember2025-01-012025-03-310002001557us-gaap:IntersegmentEliminationMember2024-01-012024-03-310002001557innv:ConvertibleDebenturesTrancheOneMemberus-gaap:ConvertibleDebtMemberus-gaap:SubsequentEventMember2025-04-140002001557innv:ConvertibleDebenturesTrancheOneMemberus-gaap:ConvertibleDebtMemberus-gaap:SubsequentEventMember2025-04-142025-04-140002001557us-gaap:SubsequentEventMemberinnv:WTILenderMember2025-04-140002001557us-gaap:SeriesBPreferredStockMemberus-gaap:SubsequentEventMember2025-04-162025-05-060002001557us-gaap:SeriesCPreferredStockMemberus-gaap:SubsequentEventMember2025-04-162025-05-060002001557us-gaap:CommonStockMemberus-gaap:SeriesBPreferredStockMemberus-gaap:SubsequentEventMember2025-04-162025-05-060002001557us-gaap:CommonStockMemberus-gaap:SeriesCPreferredStockMemberus-gaap:SubsequentEventMember2025-04-162025-05-060002001557us-gaap:SubsequentEventMemberinnv:StandbyEquityPurchaseAgreementMember2025-05-022025-05-020002001557us-gaap:SubsequentEventMemberinnv:StandbyEquityPurchaseAgreementMember2025-05-020002001557innv:ConvertibleDebenturesTrancheTwoMemberus-gaap:ConvertibleDebtMemberus-gaap:SubsequentEventMember2025-05-150002001557innv:ConvertibleDebenturesTrancheTwoMemberus-gaap:ConvertibleDebtMemberus-gaap:SubsequentEventMember2025-05-152025-05-15

___________________________

___________________________

For the transition period from to

Commission file number 001-42303

___________________________

(Exact name of registrant as specified in its charter)

___________________________

Registrant’s telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:

Securities registered pursuant to section 12(g) of the Act: None

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes o No x

As of April 25, 2025, the registrant had 53,487,294 shares of common stock outstanding.

Unless the context requires otherwise, references in this Quarterly Report on Form 10-Q (“Form 10-Q”) to “Innventure,” the “Company,” “we,” “our” or “us” refer to Innventure, Inc. and its consolidated subsidiaries.

This Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including statements about the Company’s business model, the financial condition, results of operations, earnings outlook and the prospects for AeroFlexx, LLC (“AeroFlexx” or “AFX”), Accelsius Holdings LLC (“Accelsius” or “ACC”) and Refinity Olefins, LLC (“Refinity” and, together with AeroFlexx and Accelsius, the “Innventure Companies” and, together with those subsidiary companies that Innventure may found, fund, and operate going forward, the “Operating Companies”). In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Forward-looking statements generally relate to future events or the Company’s future financial or operating performance and may refer to projections and forecasts. Forward-looking statements are often identified by future or conditional words such as “plan,” “believe,” “expect,” “anticipate,” “intend,” “outlook,” “estimate,” “forecast,” “project,” “continue,” “could,” “may,” “might,” “possible,” “will,” “potential,” “predict,” “should,” “would” and other similar words and expressions (or the negative versions of such words or expressions), but the absence of these words does not mean that a statement is not forward-looking.

The forward-looking statements are based on the current expectations of the Company’s management and are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of this Form 10-Q. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. The risks and uncertainties include, but are not limited to, those factors discussed and identified in the section of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “2024 Annual Report”) entitled “Risk Factors,” those discussed and identified in other public filings made with the Securities and Exchange Commission (the “SEC”) by the Company and the following:

•expectations regarding Innventure’s and the Innventure Companies’ (as defined below) strategies and ability to achieve future financial performance, including their respective future business plans, expansion and acquisition plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures, and Innventure’s ability to invest in growth initiatives;

•the implementation, market acceptance and success of Innventure’s and the Innventure Companies’ business models and growth strategies;

•sustained unfavorable economic or other conditions which could cause the need for Innventure to evaluate and potentially record additional impairment charges for all, or a portion of, its goodwill and other intangible assets;

•Innventure’s future capital requirements and sources and uses of cash, including its ability to obtain funding for its operations and future growth and to continue as a going concern;

•Innventure’s ability to meet the various conditions imposed by, and to satisfy its obligations to, the WTI Lenders (as defined below), under the WTI Facility (as defined below);

•Innventure’s ability to meet the various conditions and satisfy the various limitations under the Standby Equity Purchase Agreement (the “SEPA”) and securities purchase agreement (the “Securities Purchase Agreement”), each with YA II PN, Ltd. (“Yorkville”), including exchange caps, issuances and subscriptions based on trading volumes, to continue to access the funds available under the SEPA or the Securities Purchase Agreement and related Convertible Debentures (as defined below) due to certain conditions, restrictions and limitations set forth therein;

•certain restrictions and limitations set forth in Innventure’s debt instruments, which may impair Innventure’s financial and operating flexibility;

•Innventure’s and the Innventure Companies’ ability to generate liquidity and maintain sufficient capital to operate as anticipated;

•the risk that the technology solutions that Innventure and the Innventure Companies license or acquire from third parties or develop internally may not function as anticipated or provide the benefits anticipated;

•developments and projections relating to Innventure’s and the Innventure Companies’ competitors and industry;

•the ability of Innventure and the Innventure Companies to scale the operations of their respective businesses;

•the ability of Innventure and the Innventure Companies to establish substantial commercial sales of their products;

•the ability of Innventure and the Innventure Companies to compete against companies with greater capital and other resources or superior technology or products;

•Innventure and the Innventure Companies’ ability to meet, and to continue to meet, applicable regulatory requirements for the use of their products and the numerous regulatory requirements generally applicable to their respective businesses;

•the outcome of any legal proceedings against Innventure or the Innventure Companies;

•Innventure’s ability to find future opportunities to license or acquire breakthrough technology solutions from multinational corporations (“MNCs”) or other third parties (collectively, “Technology Solutions Providers”) and to satisfy the requirements imposed by or to avoid disagreements with its current and future Technology Solutions Providers;

•the risk that the launch of new companies distracts Innventure’s management from its subsidiaries and their respective operations;

•the risk that Innventure may be deemed an investment company under the Investment Company Act of 1940 (the “Investment Company Act”), which would impose burdensome compliance requirements and restrictions on its activities;

•Innventure’s ability to sufficiently protect the intellectual property (“IP”) rights of itself and its Operating Companies, and to avoid or resolve in a timely and cost-effective manner any disputes that may arise relating to its use of the IP of third parties;

•the risk of a cyber-attack or a failure of Innventure’s information technology and data security infrastructure;

•the ability to recognize the anticipated benefits of the Business Combination;

•geopolitical risk and changes in applicable laws or regulations, including with respect to foreign trade policy and tariffs;

•potential adverse effects of other economic, business, and/or competitive factors;

•operational risks related to Innventure and the Innventure Companies, which have limited or no operating history; and

•the limited liquidity and trading of Innventure’s securities.

Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. All forward-looking statements in this Form 10-Q are made as of the date hereof, based on information available to Innventure as of the date hereof, and Innventure assumes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required under applicable law.

			Successor									Predecessor
			Three months ended March 31, 2025									Three months ended March 31, 2024
Revenue			$	224								$	224
Operating Expenses
Cost of sales			184									—
General and administrative			19,676									7,904
Sales and marketing			2,096									1,183
Research and development			6,253									1,669
Goodwill impairment			233,213									—
Total Operating Expenses			261,422									10,756
Loss from Operations			(261,198)									(10,532)
Non-operating (Expense) and Income
Interest expense, net			(1,538)									(405)
Net gain on investments			—									5,189
Net loss on investments - due to related parties			—									(186)
Change in fair value of financial liabilities			16,429									(478)
Equity method investment (loss) gain			(6,756)									5
Realized gain on conversion of available for sale investment			1,507									—
Loss on extinguishment of related party debt			(3,538)									—
Loss on conversion of promissory notes			—									(1,119)
Miscellaneous other income			21									—
Total Non-operating Income			6,125									3,006
Loss before income taxes			(255,073)									(7,526)
Income tax benefit			(1,399)									—
Net Loss			(253,674)									(7,526)
Less: net loss attributable to
Non-redeemable non-controlling interest			(110,677)									(2,307)
Net Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders			(142,997)									(5,219)
Basic and diluted loss per share			$	(3.10)
Basic and diluted weighted average common shares			46,252,922
Other comprehensive loss, net of taxes:
Unrealized loss on available for sale debt securities - related party			(880)									—
Reclassification of realized gain on conversion of available for sale investments			(1,507)									—
Total other comprehensive loss, net of taxes			(2,387)									—
Total comprehensive loss, net of taxes			(256,061)									(7,526)
Less: comprehensive loss attributable to
Non-redeemable non-controlling interest			(110,677)									(2,307)
Net Comprehensive Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders			$	(145,384)								$	(5,219)

    

			Successor									Predecessor
			Three months ended March 31, 2025									Three months ended March 31, 2024
Supplemental Cash Flow Information
Cash paid for interest			$	1,127								$	55
Supplemental Disclosure of Noncash Financing Information
Accretion of redeemable units to redemption value			—									4,415
Issuance of units to non-controlling interest in exchange of convertible promissory notes			—									7,324
Conversion of working capital loans to equity method investee into investments in debt securities - related party			4,375									—
Extinguishment of debt with Series C Preferred Stock			14,000									—
Contribution of Series C Preferred Stock to equity method investee			5,783									—
Conversion of AFX available-for-sale term loan into equity method investments			8,757									—
Issuance of stock in exchange for services			4,002									—
Equity reallocation between non-controlling interest and additional paid-in capital			26,304									—

Unless the context otherwise requires, references herein to "Innventure", "we", "us", "our" and "the Company" refer to the business and operations of Innventure LLC and its consolidated subsidiaries (the “Predecessor”) for all periods prior to the Closing (as defined below) and to the business and operations of Innventure, Inc., and its consolidated subsidiaries (the “Successor”) for all periods after Closing. All balance sheet amounts presented are for Successor periods.

Innventure founds, funds, and operates companies with a focus on transformative, sustainable technology solutions that we acquire or license from technology innovators, which are typically MNCs. As owner-operators, our goal is to take what we believe to be breakthrough technologies from evaluation to scaled commercialization utilizing an approach designed to help mitigate risk in collaboration with the MNCs (our channel partner(s)), as we build disruptive companies that we believe have the potential to achieve a target enterprise value of at least $1 billion. We define ‘‘disruptive’’ as innovations that, in our opinion, have the ability to significantly change the way businesses, industries, markets, and/or consumers operate. Innventure, Inc., is headquartered in Orlando, Florida.

As further discussed in our 2024 Annual Report, on October 2, 2024 (the “Closing Date” or “Closing”), Learn CW Investment Corporation (“Learn CW”), a Cayman Islands exempted company, and Innventure LLC, a Delaware limited liability company, consummated a business combination (the “Business Combination”) pursuant to the terms of the Business Combination Agreement previously entered into on October 24, 2023. Following the Closing, both Learn CW and Innventure LLC became subsidiaries of Learn SPAC HoldCo, Inc. (“Holdco”), a Delaware corporation and direct, wholly-owned subsidiary of Learn CW prior to Closing. Holdco changed its name to “Innventure, Inc.” and became a publicly traded company. Holdco was determined to be the accounting acquirer. Innventure, Inc., and its subsidiaries are the successor to Innventure LLC following the Business Combination.

The information provided in this Quarterly Report on Form 10-Q reflects two distinct periods, the period up to the Closing Date labeled as the Predecessor and the period including and after that date labeled as the Successor. The Business Combination was accounted for using the acquisition method of accounting and the Successor financial statements reflect a new basis of accounting that is based on the fair value of the net assets acquired. As a result of the application of the acquisition method of accounting as of the Closing Date, the accompanying condensed consolidated financial statements include a black line division which indicates that the Predecessor and Successor reporting entities shown are presented on a different basis and are therefore, not comparable.

These condensed consolidated financial statements are unaudited and should be read in conjunction with the Company's most recent annual audited consolidated financial statements and notes thereto. These condensed consolidated financial statements have been prepared in accordance with the instructions for the Securities and Exchange Commission’s (“SEC’s”) Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP") have been condensed or omitted pursuant to rules and regulations of the SEC, although the Company believes that the disclosures are adequate to make the information presented not misleading. In the opinion of management, all adjustments, consisting only of normal recurring adjustments considered necessary for a fair presentation of results of operations and financial position, have been included.

We use the same accounting policies in preparing quarterly and annual financial statements.

During the three months ended March 31, 2025 (Successor), we identified an error and recorded an immaterial out of period adjustment of $10,464 to correct an overstatement of Additional paid-in capital, an immaterial out of period adjustment of $4,454 to correct understatement of Net loss attributable to Innventure, Inc. stockholders and an immaterial out of period adjustment of $14,918 to correct an understatement of Non-controlling interest.

The impact of the adjustments are not material to the condensed consolidated financial statements for any interim or annual periods prior to March 31, 2025 nor the current financial period. The out of period adjustment to Additional paid-in capital is included in the Non-controlling interest issued and related transfers within the consolidated statements of changes in mezzanine and stockholders' equity (deficit) and the adjustment related to Net loss attributable to Innventure, Inc. within Comprehensive loss attributable to Non-redeemable non-controlling interest on the condensed consolidated statements of operations and comprehensive income (loss).

Certain amounts reported previously have been reclassified to conform to the current year presentation with no effect on total stockholders' deficit, or net income as previously reported.

As of March 31, 2025, the Company had cash balance of $1,375, accumulated deficit of $221,285 and a working capital deficit of $37,039. During the three months ended March 31, 2025 (Successor), the Company incurred a net loss of $253,674. We have experienced recurring losses from operations and negative cash flows from operating activities. In addition, we continue to have an ongoing need to raise significant additional cash from outside sources to sustain our operations and fund our growth plans.

In connection with our assessment of going concern considerations in accordance with FASB’s ASU 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about our ability to continue as a going concern within one year after the date of the condensed consolidated financial statements included in Item 1. of this Form 10-Q. If we are unable to obtain adequate capital from public or private equity or debt financing (including the SEPA), or otherwise generate sufficient revenues from our Operating Companies to support our cost structure within the normal operating cycle of a twelve (12) month period, we may have to implement cost reduction measures or adjust the timing or scope of certain operations at Innventure or certain Innventure Companies, in part or in full, to help manage liquidity. If we raise additional funds through the issuance of additional debt or equity securities, it could result in substantial dilution to our existing stockholders and increased fixed payment obligations, and these securities may have rights senior to those of our Common Stock. See “Item 1A. Risk Factors – Risks Related to Innventure’s Business – There is uncertainty regarding Innventure’s ability to maintain liquidity sufficient to operate its business effectively, which raises substantial doubt about its ability to continue as a going concern.” in our 2024 Annual Report.

The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern within one year after the date of the accompanying condensed consolidated financial statements are issued; however, the above conditions raise substantial doubt about the Company’s ability to do so. The condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. There can be no assurance that management will be successful in implementing its business plan or that the successful implementation of such business plan will improve our operating results.

In November 2023, the Financial Accounting Standard Board’s (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures ("ASU 2023-07"), which enhances prior reportable segment disclosure requirements in part by requiring entities to disclose significant expenses related to their reportable segments.

The amendments in ASU 2023-07 are effective on a retrospective basis for annual periods beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The Company has made the required disclosures related to this ASU within Note 17. Business Segment Data.

In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative (“ASU 2023-06”). This standard modifies the disclosure or presentation requirements of a variety of topics and aligns requirements with the SEC’s existing disclosure requirements. ASU 2023-06 is effective on the date each amendment is removed from Regulation S-X or Regulation S-K with early adoption prohibited. The Company will monitor the removal of various requirements from the current regulations in order to determine when to adopt the related amendments but does not anticipate the adoption of the new guidance will have a material impact on the Company’s condensed consolidated financial statements. The Company will continue to evaluate the impact of this guidance on its condensed consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"), which requires disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid to enhance the transparency and decision usefulness of income tax disclosures. The amendments in this ASU are effective for annual periods beginning after December 15, 2024 on a prospective basis. The Company is currently evaluating the impact that the adoption of this accounting standard will have on its condensed consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03"). In January 2025, the FASB issued Clarifying the Effective Date (“ASU 2025-01”) to add some clarity around the effective date of the guidance. ASU 2024-03 requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. The new standard is effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied either prospectively, to financial statements issued after the effective date, or retrospectively, to all prior periods presented. The Company is currently evaluating the impact that the adoption of this accounting standard will have on its condensed consolidated financial statements.

The Innventus ESG Fund I, L.P. (the “ESG Fund”) is an investment company that follows a specialized basis of accounting established by GAAP. The Company’s general partnership interest in the ESG Fund is substantially illiquid. While the ESG Fund’s holdings are accounted for at fair value, the equity-method investment in the ESG Fund is adjusted to reflect the fair value of the underlying investments of the ESG Fund as of March 31, 2025 and December 31, 2024. The fair value of the underlying investments in the ESG Fund is based on the Company’s assessment, which takes into account expected cash flows, earnings multiples and/or comparisons to similar market transactions, among other factors.

Valuation adjustments reflecting consideration of credit quality, concentration risk, sales restrictions and other liquidity factors are integral to valuing these instruments.

The Company held a 38% and 34% equity method investment interest in AeroFlexx as of March 31, 2025 and December 31, 2024, respectively.

On July 1, 2024, the Company entered into a loan agreement with AeroFlexx under which the Company will lend up to $10,000 to AeroFlexx.

The term loans and any unpaid accrued interest are required to be repaid by the maturity date, which is the earlier of (i) December 31, 2026 or (ii) the date of the sale, transfer or other disposition all of AeroFlexx’s assets or AeroFlexx's stock. After any full or partial repayment of the term loans, AeroFlexx may borrow additional funds up to the $10,000 limit until the maturity date. The loans bear interest at the applicable federal rate published by the Internal Revenue Service and is adjusted on a quarterly basis.

The Company has an option to convert the outstanding principal amount of the term loans and any unpaid accrued interest into shares or units in connection with the next issuance of equity securities by AeroFlexx, at a price equal to 100% of the price per share or unit and on the same terms and conditions as apply to such issuance.

During 2024, the Company lent AeroFlexx the entire $10,000 principal balance under this agreement. As of January 1, 2025, AeroFlexx was unable to raise any additional equity financing, therefore the outstanding principal and unpaid accrued interest with an amount equal to the equity deficit of $7,250 was automatically converted into Class D preferred units of AeroFlexx at the price of $6.83 per share in accordance with the loan agreement. Upon conversion, a realized gain of $1,507 was recognized for the three months ended March 31, 2025 (Successor) and is included in non-operating income in the condensed consolidated statements of operations and comprehensive income (loss).

During the three months ended March 31, 2025 (Successor), $4,375 was reclassified from Due from related parties under the term loan and $2,337 was drawn down by AeroFlexx under the term loan. The total balance drawn as of March 31, 2025 was $9,629.

The Company accounted for the loans as an investment in debt securities and classified them as available for sale debt securities. Based on the AFS classification, the Company records this investment at fair value at each reporting date and as such recorded the changes in fair value of these loans (including the adjustment to fair value at inception date) in Other comprehensive income ("OCI").

As the contractual maturity of the loan is in 2026, it is included in the non-current line item Investments of the condensed consolidated balance sheets. The change in fair value of this investment in debt securities of $880 for the three months ended March 31, 2025 (Successor) is included as Unrealized loss on available for sale debt securities - related party in the condensed consolidated statements of operations and comprehensive income (loss).

The following tables present the Company’s fair value hierarchy for assets and liabilities measured at fair value on a recurring basis as of March 31, 2025 and December 31, 2024:

Gains and losses for such assets and liabilities categorized within the Level 3 table set forth may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).

Changes in the estimated fair value of Level 3 financial assets and liabilities that are measured on a recurring basis for the three months ended March 31, 2025 (Successor) and the three months ended March 31, 2024 (Predecessor), respectively, are as follows:

There were no transfers in or out of levels during the three months ended March 31, 2025 (Successor) nor for the three months ended March 31, 2024 (Predecessor).

The following table summarizes the significant unobservable inputs (Level 3):

As further discussed in Note 3. Investments, an outstanding principal and accrued interest of $7,250 for the investment in debt securities - AFS was automatically converted into Class D preferred units in accordance with the loan agreement. Prior to the conversion, the fair value was estimated using a Black Scholes model. Post conversion, the fair value is estimated using a discounted cash flow model by discounting the contractual debt cash flows at a rate incorporating the credit risk of AeroFlexx.

For further information on the Earnout Shares and WTI Warrants, refer to Note 9. Earnout Shares and Note 10. Warrants, respectively.

The Company's debt is carried on a historical cost basis net of unamortized discounts and premiums. Costs associated with acquiring debt are presented in the condensed consolidated balance sheets as a direct deduction from the carrying amount of the debt as a debt discount. Discounts on debt are amortized over the contractual life of the related debt instrument using the effective interest method (unless otherwise specified below) and are included in Interest expense, net in the condensed consolidated statements of operations and comprehensive income (loss).

The Company’s notes payable, excluding debt issuance costs, mature as follows:

In 2018, the Company authorized the issuance and sale of unsecured promissory notes to investors up to $35,000. From 2018 to 2021, the Company issued promissory notes with a total principal amount of $4,936. The notes require monthly interest payments, have an original maturity period of 36-48 months, and bear interest at 9%-12% per annum. The notes contain two term extension options, at the Company’s election, which can extend the notes’ maturity period to 60 months in total. If the Company elects its first term extension option, the note will bear interest at 12% for months 36 through 48. If the Company elects its second term extension option, the notes will bear interest at 15% for months 48 through 60.

Extensions on Series 1 promissory notes were as follow:

Interest expense on Series 1 promissory notes was as follows:

The Company entered into unsecured promissory notes with two related parties, the first on August 20, 2024, for a principal amount of $10,000, and the second on August 22, 2024, for a principal amount of $2,000. The Company entered into amended and restated agreements to amend the terms of these unsecured promissory notes on October 1, 2024. As per the original agreements, the note with the first party contained a loan fee of $1,000 which was payable with the repayment of the principal amount of the note and the note with the second party contained interest at the rate of 11.50% per annum. These notes were subsequently amended on October 1, 2024.

Interest expense on the related party notes was as follows:

In addition to the related party notes above, the Company also has a related party note for $1,000 through an unsecured promissory note with an additional related party dated May 2, 2024. As per the terms of the executed agreement, the principal amount became due on December 21, 2024 and interest will accrue at the rate of 8.00% per annum. Upon maturity, the Company is required to repay the outstanding principal amount of $1,000 and a loan fee equal to approximately $63.

On March 20, 2025, in connection with the issuance of Series C Preferred Stock (as defined below), the Company extinguished the outstanding amount of related party notes. The Company recognized a loss of $3,538 in Loss on extinguishment of related party debt on the condensed consolidated statements of operations and comprehensive income (loss) for the three months ended March 31, 2025 (Successor).

On October 22, 2024, the Company entered into a term loan with WTI Fund X, Inc. and WTI Fund XI, Inc., (collectively, “WTI Lenders”). The terms of the loan provides for a term loan facility in the aggregate principal amount of up to $50,000 (the "WTI Facility"). The total aggregate principal was available in three separate tranches subject to the Company meeting certain conditions. The Company received $20,000 (the “First Tranche”) on November 15, 2024. The First Tranche, principal and interest, shall be repaid over a period of 30 months in equal, monthly installments, commencing after an initial 12-month period of interest-only monthly payments, resulting in a total term of 42 months. The interest rate on the outstanding principal amounts under the WTI Facility for the three months ended March 31, 2025 (Successor) was 13.50%.

Borrowings under the WTI Facility will accrue interest at a rate per annum equal to the greater of (i) the “prime rate” of interest, as published by The Wall Street Journal on the date that the WTI Lenders prepare the promissory notes for the borrowings under such tranche, plus 5% and (ii) 13.50% and will amortize, after an interest-only period of twelve months in the case of the First Tranche in equal monthly installments over a period of thirty months. Obligations are secured by a lien on the majority of the assets of Innventure LLC and Innventure, Inc.

In connection with the WTI Facility, the Company issued WTI Warrants to the WTI Lenders (as further defined and described in Note 10. Warrants). The Company accounted for each of the WTI Warrants as detachable warrants at their fair value. The fair value of the WTI Warrants was recorded as a liability and as a discount to the WTI Facility on the condensed consolidated balance sheets. The Company is amortizing the discount over the term of the WTI Facility using the straight-line method.

Interest expense on this facility was as follows:

On March 25, 2025, the Company entered into a securities purchase agreement related to the issuance and sale of convertible debentures (“Convertible Debentures”) with an aggregate principal amount of up to $30,000. These Convertible Debentures will be convertible into shares of the Company’s common stock, $0.0001 par value, (“Common Stock”) (as converted, the “Conversion Shares”). The Company will issue the aggregate principal amount of Convertible Debentures in two tranches tied to separate reporting and filing requirements. As of March 31, 2025, the Company had not yet met the required reporting and filing requirements and therefore had not issued these Convertible Debentures. See Note 18. Subsequent Events for further details on this agreement.

In addition to annual impairment testing of goodwill, which is performed in the fourth quarter of each fiscal year, the Company continuously monitors for events and circumstances that could negatively impact the key assumptions used in determining fair value and therefore would require interim impairment testing, including long-term revenue growth projections, profitability, discount rates, volatility in the Company's market capitalization and general industry, market and macroeconomic conditions. During the three months ended March 31, 2025 (Successor), the Company recorded a $233,213 non-deductible, non-cash goodwill impairment charge within the condensed consolidated statements of operations and comprehensive income (loss) due to sustained decreases in the Company’s publicly quoted share price and market capitalization, which were, at least in part, sensitive to the general downward volatility experienced in the stock market during late February and March.

The Company’s March 31, 2025 goodwill impairment testing was performed using the income approach via a discounted cash flow model. The income approach estimates fair value by converting future cash flows to a current amount on the measurement date after taking into consideration marketplace conditions. Assumptions including discount rate and estimated future cash flows had a significant impact to the estimated fair value of the reporting unit.

In the event there are further adverse changes in the Company’s projected cash flows or further changes in key assumptions, including but not limited to an increase in the discount rate and further decline in the Company’s stock price, the Company may be required to record additional non-cash impairment charges to goodwill. Such non-cash charges could have a material adverse effect on the Company’s condensed consolidated statements of operations and comprehensive income (loss) and condensed consolidated balance sheets in the reporting period of the charge.

There were no intangible assets on the condensed consolidated balance sheets during the Predecessor periods; therefore, no amortization expense was recognized. Amortization expense was $5,403 for the three months ended March 31, 2025 (Successor) and is recorded within General and administrative and Research and development on the condensed consolidated statements of operations and comprehensive income (loss).

Estimated future amortization expense is as follows:

As further discussed in our 2024 Annual Report, upon Closing of the Business Combination, 5,000,000 “Company Earnout Shares” were contingently issuable and 344,828 “Sponsor Earnout Shares” were issued subject to clawback provisions. The Company Earnout Shares and the Sponsor Earnout Shares are collectively referred to as the “Earnout Shares” and are subject to certain vesting provisions.

On January 7, 2025, a total of 344,828 Sponsor Earnout Shares fully vested and were no longer subject to contingencies as the Company’s public stock price had surpassed $11.50 for twenty consecutive days, thereby fulfilling the vesting provision for the Sponsor Earnout Shares. These vesting conditions are not effective on the Company Earnout Shares until 6 months following the Business Combination.

On January 8, 2025, the Board formally recognized the creation of the Refinity subsidiary, thereby meeting the milestone two conditions for the Company Earnout Shares. As such, 2,000,000 shares of Common Stock were issued on February 4, 2025 as a result of the satisfaction of the milestone.

The Earnout Shares related to milestone three are liability classified and were fair valued at $7,470 and $14,752 as of March 31, 2025 and December 31, 2024, respectively. The Company recognized a gain of $6,409 in Change in fair value of financial liabilities on the condensed consolidated statements of operations and comprehensive income (loss) for the three months ended March 31, 2025 (Successor).

There were no warrants outstanding during the three months ended March 31, 2024 (Predecessor).

The Company’s equity-classified public warrants were measured at fair value at Closing using the warrant price at Closing and will not be subsequently re-measured. The public warrants will expire on October 2, 2029 or earlier upon redemption or liquidation and are exercisable for $11.50 per share.

The Company’s liability-classified private placement warrants are measured at fair value based on the price of the public warrants (Level 2 fair value measurement). The private placement warrants will expire on October 2, 2029 or earlier upon redemption or liquidation and are exercisable for $11.50 per share. As of March 31, 2025 (Successor) and December 31, 2024 (Predecessor), the fair value of the private placement warrants is $10,653 and $16,793, respectively, and is presented as a current liability in the condensed consolidated balance sheets. For the three months ended March 31, 2025 (Successor), the Company recognized a gain of $6,140 in Change in fair value of financial liabilities on the condensed consolidated statements of operations and comprehensive income (loss).

On October 22, 2024, in connection with the WTI Facility, the Company issued warrants (the "WTI Warrants") to the WTI Lenders. The WTI Warrants are considered freestanding financial instruments and are recorded at fair value on the condensed consolidated balance sheets as a warrant liability in the amount of $13,350 and $17,230 as of March 31, 2025 (Successor) and December 31, 2024 (Predecessor), respectively. For the three months ended March 31, 2025 (Successor), the Company recognized a gain of $3,880 in Change in fair value of financial liabilities on the condensed consolidated statements of operations and comprehensive income (loss). The WTI Warrants expire on March 31, 2035. See Note 4. Fair Value for details on the valuation.

For periods prior to the Business Combination on October 2, 2024, the Predecessor had Class B Preferred Units, Class B-1 Preferred Units, Class A Units and Class C Units issued and outstanding. In connection with the Business Combination, the Successor acquired all membership interests that were in existence for the Predecessor.

The Company is authorized to issue 25,000,000 shares of preferred stock with a par value of $0.0001 per share.

As of March 31, 2025, 3,000,000 shares of the authorized preferred stock are designated as Series B preferred stock (“Series B Preferred Stock”).

Series B Preferred Stock is entitled to an 8% annual rate dividend. On March 19, 2025, the Company distributed 21,808 shares of Series B Preferred Stock to represent $218 in cumulative dividends for Series B Preferred Stock, covering the period from the initial issue date, as defined in the Certificate of Designation, to December 31, 2024, as a payment in kind at the specified rate. As a result, the Company had a total of 1,118,808 shares of Series B Preferred Stock issued and outstanding as of March 31, 2025. As of March 31, 2025, the Company accrued $217 for the 8% dividend in the Obligation to issue equity on the condensed consolidated balance sheets.

As of March 31, 2025, 5,000,000 shares of the authorized preferred stock are designated as series C preferred stock (the “Series C Preferred Stock”). On March 24, 2025, Innventure issued 2,885,848 shares of Series C Preferred Stock at the original issue price for a total amount of $28,858,480. The consideration received by the Company was in the form of cash, services rendered and the cancellation of related party debt. The Series C Preferred Stock is subject to similar terms and conditions as the Series B Preferred Stock and is contingently redeemable for Common Stock and is recorded in mezzanine equity as of March 31, 2025. As a result, the Company had a total of 2,885,848 shares of Series C Preferred Stock issued and outstanding as of March 31, 2025. As of March 31, 2025, the Company accrued $44 for the 8% dividend in the Obligation to issue equity on the condensed consolidated balance sheets.

The Company is authorized to issue 250,000,000 shares of Common Stock with a par value of $0.0001 per share. Holders of the Company’s Common Stock are entitled to one vote for each share. As of March 31, 2025 there were 47,103,800 shares of Common Stock issued and outstanding.

For the three months ended March 31, 2025 (Successor), the Company sold 73,993 shares of Common Stock under the SEPA, raising $931 which is classified within Issuance of common shares, net of issuance costs in the consolidated statements of changes in mezzanine and stockholders' equity (deficit). As of March 31, 2025, the maximum remaining availability under the SEPA is approximately $72,000.

In December 2023, the Company entered into an agreement to receive financial advisory services in exchange for equity. Upon Closing of the Business Combination, the Company became liable for $441 of Common Stock divided by the conversion price of $10.87, resulting in 40,552 shares. In connection with the closing of the WTI Facility mentioned in Note 5. Borrowings, the Company became liable for $500 worth of Common Stock calculated as the volume-weighted average price of the Common Stock over the five consecutive trading days ending on the trading day immediately preceding November 15, 2024, $11.13, for a total of 44,919 shares. On February 3, 2025, the Company has issued the aggregate 85,471 shares of Common Stock for services rendered.

In October 2023, the Company entered into an agreement to receive financial advisory services in exchange for equity. Upon Closing of the Business Combination, the Company was obligated to pay a success fee in cash in an amount of $600 and equity success fee in $3,000 of Series C Preferred Stock at $10.00 per share. On March 24, 2025, the Company issued the 300,000 shares of Series C Preferred Stock for services rendered.

During the three months ended March 31, 2025 (Successor), the Company recognized compensation costs related to the restricted stock units of $3,916 in the condensed consolidated statements of operations and comprehensive income (loss). As of March 31, 2025, the Company had $19,325 in stock-based compensation expense remaining to be recognized over approximately 1.5 years.

On February 26, 2025, the Company issued 140,000 stock options to two independent contractors through two separate agreements. The stock options were granted with an exercise price of $8.84. Using the Black-Scholes option pricing model, the estimated grant date fair value of stock options was $4.97 per option based on an expected volatility of 56%, an expected option term of approximately 5.9 years, and risk-free rate of return of 4.06%. The stock options have a maximum contractual life of 10 years from the grant date.

During the three months ended March 31, 2025 (Successor), the Company recognized compensation costs related to the stock options of $1,027 in the condensed consolidated statements of operations and comprehensive income (loss). As of March 31, 2025, the Company had $5,732 in compensation expense remaining to be recognized over approximately 1.7 years.

In 2024, the Company issued 30,000 cash-settled stock appreciation rights (“SARs”) which were recognized at their fair value as of the date of the grant. These SARs entitle participants to cash equal to the value of the appreciation in Accelsius’ stock price over the base price established of $12.175. These cash-settled SARs are liability classified and are revalued at each reporting period. The SARs were valued using the Black-Scholes option-pricing model based on an expected volatility of 70%, an expected term of approximately 1.75 years, and risk-free rate of return of 4%. The Company recognized a decrease in compensation expense in the amount of $442 in relation to the change in fair value of the cash-settled SARs for the three months ended March 31, 2025 (Successor).

During the three months ended March 31, 2025 (Successor) there were no Class C units granted under the Accelsius Subsidiary Equity Plan. During the three months ended March 31, 2024 (Predecessor), there were 129,700 Class C units granted with a grant date fair value per share of $4.41.

The Company recognized compensation costs related to the Accelsius Subsidiary Equity Plan of $898 and $345 for the three months ended March 31, 2025 (Successor) and the three months ended March 31, 2024 (Predecessor), respectively, in the condensed consolidated statements of operations and comprehensive income (loss). As of March 31, 2025, the Company had $6,673 in unit-based compensation expense remaining to be recognized over approximately 2.21 years.

During the three months ended March 31, 2025 (Successor), the Company recognized income tax benefits of $1,399. During the three months ended March 31, 2024 (Predecessor), no income tax provision or expense was recorded.

For interim tax reporting, the Company estimated one single effective tax rate for tax jurisdictions not subject to a valuation allowance, which is applied to the year-to-date pre-tax book loss. Tax effects of significant unusual or infrequently occurring items are excluded from the estimated annual effective tax rate calculation and recognized in the interim period in which they occur. The effective tax rate for the three months ended March 31, 2025 (Successor) was a benefit of 0.55% driven primarily by the impact of the goodwill impairment, which is not deductible for tax purposes.

The Company follows the two-class method when computing net loss per common share when shares are issued that meet the definition of participating securities. The two-class method requires income available to common shareholders for the period to be allocated between common shares and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The two-class method also requires losses for the period to be allocated between common shares and participating securities based on their respective rights if the participating security contractually participates in losses. As holders of Series B Preferred Stock, Series C Preferred Stock and WTI Warrants, which are determined to be participating securities, do not have a contractual obligation to fund losses, undistributed net losses are not allocated to them for purposes of the loss per share calculation.

Given the historical structure of the Predecessor, the Company determined that the calculation of earnings per membership unit results in values that are not a valuable metric to users of these consolidated financial statements. Therefore, earnings per share (“EPS”) information is omitted for the Predecessor periods.

Presented in the table below is a reconciliation of the numerator and denominator for the EPS calculations for the three months ended March 31, 2025 (Successor):

Basic and diluted net loss per share was the same for each period presented as the inclusion of all potential Common Stock outstanding would have been anti-dilutive.

The following table presents the potential common stock outstanding that was excluded from the computation of diluted net loss per share of Common Stock for the periods presented because including them would have been antidilutive:

As more fully described in Note 5. Borrowings, the Company has various notes with affiliates, including short-term notes with three separate related parties which were settled on March 20, 2025. In addition, the Company had a convertible note to the ESG Fund as part of the 2025 Notes which was converted during the three months ended March 31, 2024 (Predecessor).

As more fully described in Note 12. Stock-based Compensation, the Company issued various equity awards to related parties throughout 2024. On December 9, 2024, the Company issued 1,246,722 restricted stock units (“RSUs”) with a grant date fair value of $15,210 and 590,163 stock options with a grant date fair value of $3,913 to a cumulative of eight directors.

On December 31, 2024, the Company issued 200,000 SARs with a grant date fair value of $7,820 to four directors and former directors. On March 22, 2024, the Company issued 100,000 Class C Units with a grant date fair value of $441 to one director under the Accelsius Subsidiary Equity Plan.

As more fully described in Note 2. Accounting Policies in our 2024 Annual Report, the Company earns a 1-2% management fee for administrative, finance and accounting, and other back-office functions from the ESG Fund. Management fees earned from the ESG Fund were $196 for the three months ended March 31, 2025 (Successor), and $197 for the three months ended March 31, 2024 (Predecessor), which is recorded as Revenue in the condensed consolidated statements of operations and comprehensive income (loss).

In March 2021, the Company entered into a purchase option agreement with the ESG Fund to sell 145,161 shares of PureCycle Technologies, Inc. (“PCT”) common stock with an exercise price of $1. The option period would have expired on July 22, 2024 and the Company measured the derivative liability at fair value, as further described in Note 4. Fair Value. The option was exercised in March 2022 and the shares are subject to the lock-up provisions. The liability due to the ESG Fund was derecognized as a result of the Business Combination.

On March 24, 2025, the Company issued 578,294 shares of Series C Preferred Stock to settle AeroFlexx’s debt with a related party. The Company considers the stock issuance to be an investment in AeroFlexx of $5,783 which was recorded in the condensed consolidated balance sheets.

On April 22, 2020, the Company entered into a guaranty with a counterparty to unconditionally guarantee PCT’s obligation to reimburse a $5,000 prepayment upon PCT’s failure to meet certain performance thresholds. Performance thresholds include the commission and construction of a plant. The guaranty has no expiration. The total amount paid by the Company under the guaranty is $0 and total interest paid is $0. As of March 31, 2025 (Successor) and December 31, 2024 (Predecessor), there was no principal outstanding under the guaranty.

In 2022, the Company entered into two agreements with an MNC to purchase in-process research and development consisting of patents, technology, and knowledge transfer related to cooling technology for critical electronic equipment in a transaction that was determined to be an asset acquisition.

Under the terms of the agreements, the Company is required to make minimum installment payments, as disclosed below, for each year of the agreement through February 1, 2040. Each installment payment shall be credited towards and set off against any royalty payments (described below) which may become due.

As such, these installment payments serve as minimum amounts due to the MNC each calendar year.

Minimum royalties included in Patent installment payables on the condensed consolidated balance sheets are due as follows:

The Company is committed to make royalty payments on direct revenue generated from the subject technology and indirect revenue generated including additional incentives based on the volume of units sold at percentage rates in the single digits to mid-teens as defined within the respective agreement. Each year the Company will pay such royalties at the higher of: (i) the minimum amount due (noted in the table above) and (ii) the royalty calculated amount based on revenue and units sold.

On December 12, 2024, the Company entered into a license agreement (the “Technology License”) with a third party to obtain exclusive rights to use certain know-how, patents, and data relating to processes for the gasification of plastic waste (the “Gasification Technology”). Ownership of the Gasification Technology will transfer to the Company for a fee of $500 contingent upon achievement of a commercial milestone, which is not yet probable.

The Company is committed to pay a semi-annual fee of $65 until ownership transfers or the Gasification Technology is no longer licensed, which is accrued on a monthly basis. During the three months ended March 31, 2025 (Successor), $33 related to the Gasification Technology was recognized within General and administrative expense in the condensed consolidated statements of operations and comprehensive income (loss).

The Company is committed to pay annual royalties based on Refinity-related gross sales and licensing revenue starting in 2025. As of March 31, 2025, no royalty payments were made to the third party.

On January 22, 2025, Refinity entered into the Framework Agreement (“Framework Agreement”) with a third party to obtain research services focusing on the further development and optimization of the Gasification Technology.

Refinity agreed to pay a minimum fee of €2,000 for the period beginning January 22, 2025 and ending April 30, 2026 (“Year 1”), and €3,000 for the period beginning May 1, 2026 and ending April 30, 2027 (“Year 2”); provided that, if the third party is unable to provide all of the services contemplated to be provided during Year 1 due to its resource constrains, any unused portion of the minimum fee for Year 1 will be deferred to Year 2 and added to the Year 2 minimum fee. Expenses for services from contracts under the Framework Agreement are recognized as incurred and are applied to the minimum fee.

The Company’s Chief Executive Officer is the Chief Operating Decision Maker (“CODM”) of the Company. The CODM makes operating decisions, allocates resources and assesses performance based on review of historical and potential future product sales, operating expenses, and net income (loss).

Based on the information utilized by the CODM to operate the Company, there is one operating segment and reportable segment, Technology. The Technology segment includes the business activities of Accelsius, a consolidated subsidiary focused on development and manufacture of data center cooling products. Other components of the Company’s consolidated information primarily include operations relating to the original platform business, service activities, Refinity, and equity method investment activities (“Other”).

The following table presents information about the Company’s Technology segment for the three months ended March 31, 2025 (Successor) and the three months ended March 31, 2024 (Predecessor). The information includes the significant expense categories and amounts regularly provided to the CODM for the reportable segment, which may reflect a different presentation than amounts presented elsewhere in the condensed consolidated financial statements. Inter-segment transactions are not eliminated from segment results when management considers those transactions in assessing the results of the Technology segment.

* Represents depreciation not already included in Cost of sales.

** Other - change in fair value of financial liabilities, loss on conversion of promissory notes, travel and other miscellaneous expenses.

The following table reconciles the reportable segment to amounts reflected in our condensed consolidated financial statements.

All long-lived assets are located entirely in the United States. Segment assets are not reviewed by the CODM and therefore are not disclosed.

In connection with the preparation of the condensed consolidated financial statements and related disclosures for the period ended March 31, 2025, management has evaluated events through May 15, 2025, which is the date the condensed consolidated financial statements were available to be issued. Events occurring after March 31, 2025 are:

On April 14, 2025, the Company issued the first tranche of Convertible Debentures with a principal amount of $20,000 in accordance with the Securities Purchase Agreement further described in Note 5. Borrowings. These Convertible Debentures resulted in gross proceeds to the Company of approximately $18,000, representing an original issue discount of 10%.

On April 14, 2025, the Company issued warrants to purchase up to 300,000 shares of Common Stock to the WTI Lenders in connection with the securities purchase agreement related to the issuance and sale of Convertible Debentures, as described in Note 5. Borrowings. These warrants serve as consideration for the WTI Lenders’ consent to the Convertible Debentures. The warrants have an exercise price of $0.01 per share and are exercisable until March 31, 2035, with additional customary rights and protections.

Between April 16 and May 6, 2025, the Company authorized the conversion of 881,688 shares of Series B Preferred Stock and 2,310,848 shares of Series C Preferred Stock for 1,763,376 and 4,621,696 shares of Common Stock, respectively. Upon conversion, all the converted Series B and Series C Preferred Stock shares were canceled and retired.

As part of the Company’s SEPA with Yorkville, on May 2, 2025, the Company sold 44,000 shares of Common Stock to Yorkville for aggregate proceeds of approximately $174. The remaining shares that could be sold to Yorkville are 4,165,314.

On May 15, 2025, the Company issued the second tranche of Convertible Debentures with a principal amount of $10,000 in accordance with the Securities Purchase Agreement further described in Note 5. Borrowings. These Convertible Debentures resulted in gross proceeds to the Company of approximately $9,000, representing an original issue discount of 10%.

Innventure founds, funds, and operates companies with a focus on transformative, sustainable technology solutions that we acquire or license from technology innovators, which are typically MNCs with the intent to maximize values for investors and other stakeholders through positive cash flow generated through holding long term positions in our Operating Companies. Refer to Item 1. Business of the Form 10-K for a detailed discussion of our business activities.

Based on the allocation of resources and assessment of financial performance by our Chief Executive Officer (who has been determined to be our Chief Operating Decision Maker), we have identified one reportable segment: Technology. The Company’s remaining operations are not reportable segments and are classified as “Other.” “Other” primarily includes the Company’s remaining operations consisting of Innventure’s original platform business, service activities, Refinity and equity method investment activities.

On October 24, 2023, Learn CW and Innventure LLC entered into a Business Combination Agreement with Holdco, LCW Merger Sub and Innventure Merger Sub. On September 30, 2024, the stockholders of Learn CW approved the Business Combination, and the Business Combination closed on the Closing Date. The Business Combination has been accounted for using the acquisition method of accounting. The Company determined the accounting acquirer to be Holdco. Accordingly, the Company recorded assets acquired, liabilities assumed and non-controlling interest at their acquisition date fair values and recognized goodwill.

As a consequence of the Business Combination, Innventure, Inc. is the successor to an SEC-registered and Nasdaq-listed company which will require Innventure to hire additional personnel and implement procedures and processes to address public company regulatory requirements and customary practices. Innventure is incurring additional annual expenses as a public company for, among other things, directors’ and officers’ liability insurance, director fees and additional internal and external accounting and legal and administrative resources, including increased audit and legal fees.

Innventure’s future results of consolidated operations and financial position may not be comparable to historical results as a result of the Business Combination.

To reflect the application of different bases of accounting as a result of the Business Combination, the tables provided below separate the Company’s results via a black line into two distinct periods as follows: (1) three months ended March 31, 2024 (labeled “Predecessor”) and (2) three months ended March 31, 2025 (labeled “Successor”).

			Successor									Predecessor
			Three months ended March 31, 2025									Three months ended March 31, 2024						Change
			($)									($)						($)						(%)
Revenue			$	224								$	224					$	—					—		%
Operating Expenses
Cost of sales			184									—						184						nil
General and administrative			19,676									7,904						11,772						148.9		%
Sales and marketing			2,096									1,183						913						77.2		%
Research and development			6,253									1,669						4,584						274.7		%
Goodwill impairment			233,213									—						233,213						nil
Total Operating Expenses			261,422									10,756						250,666						2,330.5		%
Loss from Operations			(261,198)									(10,532)						(250,666)						2,380.0		%
Non-operating (Expense) and Income
Interest expense, net			(1,538)									(405)						(1,133)						279.8		%
Net gain on investments			—									5,189						(5,189)						(100.0)		%
Net loss on investments - due to related parties			—									(186)						186						(100.0)		%
Change in fair value of financial liabilities			16,429									(478)						16,907						(3,537.0)		%
Equity method investment (loss) gain			(6,756)									5						(6,761)						(135,220.0)		%
Realized gain on conversion of available for sale investment			1,507									—						1,507						nil
Loss on extinguishment of related party debt			(3,538)									—						(3,538)						nil
Loss on conversion of promissory notes			—									(1,119)						1,119						(100.0)		%
Miscellaneous other income			21									—						21						nm*
Total Non-operating Income			6,125									3,006						3,119						103.8		%
Income tax benefit			(1,399)									—						(1,399)						nm*
Net Loss			(253,674)									(7,526)						(246,148)						3,270.6		%
Less: net loss attributable to
Non-redeemable non-controlling interest			(110,677)									(2,307)						(108,370)						4,697.4		%
Net Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders			(142,997)									(5,219)						(137,778)						2,639.9		%
Other comprehensive loss, net of taxes:
Unrealized loss on available for sale debt securities - related party			(880)									—						(880)						nil
Reclassification of realized gain on conversion of available for sale investments			(1,507)									—						(1,507)						nil
Total other comprehensive loss, net of taxes			(2,387)									—						(2,387)						nil
Total comprehensive loss, net of taxes			(256,061)									(7,526)						(248,535)						3,302.4		%
Less: comprehensive loss attributable to
Non-redeemable non-controlling interest			(110,677)									(2,307)						(108,370)						4,697.4		%
Net Comprehensive Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders			$	(145,384)								$	(5,219)					$	(140,165)					2,685.7		%

__________________

*not meaningful

Revenue was $224 for the three months ended March 31, 2025 (Successor) and $224 for the three months ended March 31, 2024 (Predecessor), showing no change period over period. Revenue was consistent as it was substantially comprised of predetermined management fee income period over period.

Cost of sales was $184 for the three months ended March 31, 2025 (Successor) and nil for the three months ended March 31, 2024 (Predecessor), an increase of $184. The increase relates primarily to inventory write-offs.

General and administrative expense was $19,676 for the three months ended March 31, 2025 (Successor) and $7,904 for the three months ended March 31, 2024 (Predecessor), an increase of $11,772, or 148.9%. The increase in expenditure was primarily attributed to an increase in professional services, legal fees and consulting fees of $2,000, amortization expense resulting from the intangibles acquired in the Business Combination of $2,240, increased equity based compensation of $5,445. The remaining increase in expenditure was due to increased employee costs.

Sales and marketing expense was $2,096 for the three months ended March 31, 2025 (Successor) and $1,183 for the three months ended March 31, 2024 (Predecessor), an increase of $913, or 77.2%. The increase was primarily due to increased compensation costs as a result of increased headcount across the business and increases in advertising and marketing-related events and expenses associated with the commercialization phase of the Technology segment.

Research and Development (“R&D”) expense was $6,253 for the three months ended March 31, 2025 (Successor) and $1,669 for the three months ended March 31, 2024 (Predecessor), an increase of $4,584, or 274.7%. The increase was primarily due to amortization of intangibles in the Technology segment and an increase in new product development costs.

Goodwill impairment, was $233,213 for the three months ended March 31, 2025 (Successor) and nil for the three months ended March 31, 2024 (Predecessor), an increase of $233,213. The increase was due to sustained decreases in the Company’s publicly quoted share price and market capitalization, which were, at least in part, sensitive to the general downward volatility experienced in the stock market during late February and March.

Interest expense, net was $1,538 for the three months ended March 31, 2025 (Successor) and $405 for the three months ended March 31, 2024 (Predecessor), an increase of $1,133, or 279.8%. The increase was primarily due to an increase in interest expense for the WTI Facility and related party notes, partially offset by convertible notes that were converted during the three months ended March 31, 2024 (Predecessor).

Net gain on investments was nil for the three months ended March 31, 2025 (Successor) and $5,189 for the three months ended March 31, 2024 (Predecessor), a decrease of $5,189, over the comparable period for the three months ended March 31, 2024 (Predecessor). The decrease was due to the de-consolidation of certain mezzanine equity as a result of the Business Combination and the gain on investment in PCT owned stock via Class PCTA units during the three months ended March 31, 2024 (Predecessor).

Net loss on investments – due to related parties was nil for the three months ended March 31, 2025 (Successor) and $186 for the three months ended March 31, 2024 (Predecessor), a decrease of $186. The decrease was primarily due to an increase in fair value of liability - PCT stock owed to others for the three months ended March 31, 2024 (Predecessor). The Class PCTA associated liabilities were de-consolidated as a result of the Business Combination.

The fair value of financial liabilities decreased by $16,429 for the three months ended March 31, 2025 (Successor) and increased by $478 for the three months ended March 31, 2024 (Predecessor), a change of $16,907, or 3,537.0%. The increase was primarily due to increases in fair value adjustments for warrants and earnout liabilities.

Equity method investment loss was $6,756 for the three months ended March 31, 2025 (Successor) and equity method investment gain was $5 for the three months ended March 31, 2024 (Predecessor), a decrease of $6,761, or 135,220.0%. The loss during the three months ended March 31, 2025 (Successor) represented allocated losses from the ESG Fund and AeroFlexx. The gain during the three months ended March 31, 2024 (Predecessor) was primarily due to an allocated gain from the ESG Fund offset by an allocated loss from investment of AeroFlexx.

Realized gain on conversion of available for sale investment was $1,507 for the three months ended March 31, 2025 (Successor) and nil for the three months ended March 31, 2024 (Predecessor), an increase of $1,507. The increase was due to the partial conversion of the AeroFlexx investment in debt securities resulting in a realized gain during the three months ended March 31, 2025 (Successor).

Loss on extinguishment of related party debt was $3,538 for the three months ended March 31, 2025 (Successor) and nil for the three months ended March 31, 2024 (Predecessor), an increase of $3,538. The increase was due to the extinguishment of certain related party debt by issuing Series C Preferred Stock during the three months ended March 31, 2025 (Successor). There was no gain or loss on extinguishment of related party debt for the three months ended March 31, 2024 (Predecessor).

Loss on conversion of promissory notes was nil for the three months ended March 31, 2025 (Successor) and $1,119 for the three months ended March 31, 2024 (Predecessor), a decrease of $1,119. This was due to the automatic conversion of promissory notes during the three months ended March 31, 2024 (Predecessor) into equity instruments which was treated as an extinguishment thereby generating a loss. There was no equivalent transaction for the three months ended March 31, 2025 (Successor).

Unrealized loss on available for sale debt securities - related party, was $880 for the three months ended March 31, 2025 (Successor) and nil for the three months ended March 31, 2024 (Predecessor), an increase of $880. The increase was due to the fair value adjustment to investments in debt securities which are classified as available for sale.

Reclassification of realized gain on conversion of available for sale investments was $1,507 for the three months ended March 31, 2025 (Successor) and nil for the three months ended March 31, 2024 (Predecessor), an increase of $1,507. The increase was due to the partial conversion of the AeroFlexx investment in debt securities resulting in a realized gain during the three months ended March 31, 2025 (Successor).

Loss attributable to non-redeemable non-controlling interests was $110,677 for the three months ended March 31, 2025 (Successor) and $2,307 for the three months ended March 31, 2024 (Predecessor), an increase of $108,370, or 4,697.4%. This was due to the increase in Accelsius net loss, primarily as a result of goodwill impairment, during the three months ended March 31, 2025 (Successor) as compared to the three months ended March 31, 2024 (Predecessor).

We use certain financial measures that are not calculated in accordance with generally accepted accounting principles in the U.S. (GAAP) to supplement our consolidated financial statements. These non-GAAP financial measures provide additional information to investors to facilitate comparisons of past and present operating results, identify trends in our underlying operating performance, and offer greater transparency on how we evaluate our business activities. These measures are integral to our processes for budgeting, managing operations, making strategic decisions, and evaluating our performance.

Our primary non-GAAP financial measures are EBITDA and Adjusted EBITDA. We define EBITDA as net income before interest, income taxes, and depreciation and amortization. Adjusted EBITDA is defined as EBITDA further adjusted to exclude certain non-cash items, non-recurring expenses, and other items that are not indicative of our core operating activities. These may include stock-based compensation, acquisition costs, and other financial items. We believe Adjusted EBITDA is valuable for investors and analysts as it provides additional insight into our operational performance, excluding the impacts of certain financing, investing, and other non-operational activities. This measure helps in comparing our current operating results with prior periods and with those of other companies in our industry. It is also used internally for allocating resources efficiently, assessing the economic outcomes of acquisitions and strategic decisions, and evaluating the performance of our management team.

There are limitations to Adjusted EBITDA, including its exclusion of cash expenditures, future requirements for capital expenditures and contractual commitments, and changes in or cash requirements for working capital needs. Adjusted EBITDA also omits significant interest expenses and related cash requirements for interest and payments. While depreciation and amortization are non-cash charges, the associated assets will often need to be replaced in the future, and Adjusted EBITDA does not reflect the cash required for such replacements. Additionally, Adjusted EBITDA does not account for income or other taxes or necessary cash tax payments.

Investors should use caution when comparing our non-GAAP measure to similar metrics used by other companies, as definitions can vary. Adjusted EBITDA should not be considered in isolation or as a substitute for GAAP financial measures. We provide Adjusted EBITDA as supplemental information to enhance the overall understanding of our financial performance.

The following table provides a reconciliation from Net Loss to EBITDA and Adjusted EBITDA for the specified periods: